Aqueous dispersion of camptothecin analogue-phospholipid complex and method for preparing same
A technology of phospholipid complex and camptothecin, which is applied in medical preparations with non-active ingredients, medical preparations containing active ingredients, liquid delivery, etc., can solve the problems of poor patient compliance and clinical use restrictions, and achieve toxic and side effects Small, highly targeted, and less residual effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Disperse 50mg of 10-hydroxycamptothecin and 3 times the molar amount of egg yolk lecithin in 100ml of tetrahydrofuran at 40°C, blow in nitrogen, connect to a reflux device and stir for 1 hour, stop the reaction, remove the organic solvent by vacuum evaporation, add the additive containing Using 50ml of water for injection, hydration for 10min, washing the film ultrasonically in a water bath to obtain an aqueous dispersion, and treating it with a high-pressure homogenizer at 400bar for 10 cycles to obtain an aqueous dispersion of hydroxycamptothecin phospholipid complex with a particle size of 117±65nm.
[0038] The above preparation was added with 2% mannitol and 3% trehalose (w / v), and freeze-dried to obtain a freeze-dried product of a phospholipid complex aqueous dispersion. The average particle size after reconstitution is 118±59nm.
[0039] Dilute it with normal saline for injection to 0.2mg / ml, take 1ml and put it in a dialysis bag (molecular weight cut-off 7000), ...
Embodiment 2
[0041] Disperse 50 mg of 9-nitrocamptothecin and 2 times the molar amount of soybean lecithin in 100 ml of acetone at 40 ° C, pass through nitrogen gas, and stir for 1 hour at 40 ° C with a reflux device to stop the reaction. Additives were dispersed in water for injection with high-speed stirring for 30 minutes, evaporated ethanol under reduced pressure, and treated the coarse dispersion with a high-pressure homogenizer at 300 bar for 50 cycles to obtain an aqueous dispersion of 9-nitrocamptothecin phospholipid complex.
[0042] The above preparation was added with 10% trehalose and 2% mannitol, and freeze-dried to obtain a freeze-dried product of phospholipid complex aqueous dispersion.
Embodiment 3
[0044] Disperse 10 mg of 9-methoxycamptothecin and 5 times the molar amount of dipalmitoylphosphatidylcholine in 100 ml of dioxane at 50°C, blow in nitrogen, connect to a reflux device and stir at 50°C for 2 hours, stop Reaction, remove dioxane by evaporation under reduced pressure, add ether to dissolve 9-methoxycamptothecin phospholipid complex, inject 50ml of water for injection containing additives at 70°C and disperse at high speed for 1hr to evaporate ether, and the coarse dispersion is passed through the probe Ultrasound (power 500w) for 5 minutes to obtain an aqueous dispersion of 9-methoxycamptothecin phospholipid complex.
[0045] The above preparation was added with 5% lactose and 2% glycine, and freeze-dried to obtain a freeze-dried product of phospholipid complex aqueous dispersion.
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com